Bristol-Myers Squibb Pharmaceutical Limited

Bristol-Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH , UK
Telephone: +44 (0)1895 523 000
Fax: +44 (0)1895 523 010
Medical Information Direct Line: +44 (0)1895 523 740
Medical Information e-mail: medical.information@bms.com
Medical Information Fax: +44 (0)1895 523 677

Patient Information Leaflet last updated on the eMC: 05/02/2010
PIL Nalorex

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 05/02/2010 and displayed until Current
Reasons for adding or updating:
  • Change to packaging
  • Change to date of revision
  • Change to storage instructions
Updated on 25/07/2008 and displayed until 05/02/2010
Reasons for adding or updating:
  • Change to storage instructions
Updated on 07/09/2006 and displayed until 25/07/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   naltrexone hydrochloride